Stock Scorecard
Stock Summary for Stryker Corp (SYK) - $337.15 as of 4/26/2024 9:52:53 AM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SYK
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SYK
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SYK
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for SYK
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for SYK
Financial Details for SYK
Company Overview |
|
---|---|
Ticker | SYK |
Company Name | Stryker Corp |
Country | USA |
Description | Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 4/30/2024 |
Stock Price History |
|
Last Day Price | 337.15 |
Last Day Price Updated | 4/26/2024 9:52:53 AM EST |
Last Day Volume | 1,615,335 |
Average Daily Volume | 1,162,960 |
52-Week High | 360.58 |
52-Week Low | 248.74 |
Last Price to 52 Week Low | 35.54% |
Valuation Measures |
|
Trailing PE | 40.83 |
Industry PE | 48.36 |
Sector PE | 61.73 |
5-Year Average PE | 22.91 |
Free Cash Flow Ratio | 42.04 |
Industry Free Cash Flow Ratio | 61.97 |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 1.58 |
Total Cash Per Share | 8.02 |
Book Value Per Share Most Recent Quarter | 48.92 |
Price to Book Ratio | 7.00 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 6.35 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 380,470,000 |
Market Capitalization | 128,275,460,500 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/27/2024 |
Last Dividend Amount | 0.80 |
Current Dividend Amount | 0.80 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 3.10 |
Trailing Annual Dividend Yield | 0.92% |
Forward Annual Dividend Rate | 3.39 |
Forward Annual Dividend Yield | 1.01% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 1.05% |
5-Year Average Dividend Yield | 1.02% |
1-Year Dividend Growth Rate Percentage | 7.58% |
3-Year Dividend Growth Rate Percentage | 8.62% |
5-Year Dividend Growth Rate Percentage | 9.33% |
All-Time Dividend Growth Rate Percentage | 21.31% |
Dividend Payout Ratio | 37.53% |
Income Statement |
|
Quarterly Earnings Growth YOY | 102.70% |
Annual Earnings Growth | 34.22% |
Reported EPS 12 Trailing Months | 8.25 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 10.60 |
Net Income Twelve Trailing Months | 3,165,000,000 |
Net Income Past Year | 3,165,000,000 |
Net Income Prior Year | 2,358,000,000 |
Quarterly Revenue Growth YOY | 11.80% |
5-Year Revenue Growth | 8.55% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 3,053,000,000 |
Total Cash Past Year | 3,053,000,000 |
Total Cash Prior Year | 1,928,000,000 |
Net Cash Position Most Recent Quarter | -10,027,000,000 |
Net Cash Position Past Year | -10,027,000,000 |
Long Term Debt Past Year | 13,080,000,000 |
Long Term Debt Prior Year | 12,965,000,000 |
Total Debt Most Recent Quarter | 13,080,000,000 |
Equity to Debt Ratio Past Year | 0.59 |
Equity to Debt Ratio Most Recent Quarter | 0.59 |
Total Stockholder Equity Past Year | 18,593,000,000 |
Total Stockholder Equity Prior Year | 16,616,000,000 |
Total Stockholder Equity Most Recent Quarter | 18,593,000,000 |
Options |
|
Put/Call Ratio | 0.32 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -4.83 |
MACD Signal | -3.37 |
20-Day Bollinger Lower Band | 284.94 |
20-Day Bollinger Middle Band | 331.35 |
20-Day Bollinger Upper Band | 377.76 |
Beta | 0.91 |
RSI | 41.23 |
50-Day SMA | 300.73 |
200-Day SMA | 251.81 |
System |
|
Modified | 4/25/2024 12:37:33 PM EST |